Physician perspective | % indicating "yes" * |
---|---|
Most important factors for stage I and II patients treated with MRM over last 2 years | Â |
   Presence of multifocal or multicentric disease | 86.2 |
   Tumor size | 71.2 |
   Patient's attitude toward preserving the breast | 66.2 |
   Breast size | 50.0 |
   Age | 28.8 |
   Location of tumor | 25.0 |
   Patient's ability/willingness to travel to receive adjuvant radiation therapy | 22.5 |
   Family history | 18.8 |
   Cosmetic result | 17.5 |
   Adverse effects/outcome | 6.2 |
Most important factors for stage I and II patients treated with BCT over last 2 years | Â |
   Patient's attitude toward preserving the breast | 87.5 |
   Tumor size | 77.5 |
   Cosmetic result | 73.8 |
   Breast size | 55.0 |
   Patient's ability/willingness to travel to receive adjuvant radiation therapy | 38.8 |
   Presence of multifocal or multicentric disease | 32.5 |
   Age | 30.0 |
   Location of tumor | 22.5 |
   Adverse effects/outcome | 7.5 |
   Family history | 6.2 |
Reasons why Asian subgroups are more likely to get MRM over BCT | Â |
   Patient's attitude toward preserving the breast | 52.5 |
   Breast size | 25.0 |
   Age | 11.2 |
   Patient's ability/willingness to travel to receive adjuvant radiation therapy | 10.0 |
   Tumor size | 8.8 |
   Adverse effects/outcome | 8.8 |
   Cosmetic result | 7.5 |
   Presence of multifocal or multicentric disease | 6.2 |
   Location of tumor | 5.0 |
   Family history | 2.5 |
   Don't know | 17.5 |
   Other | 18.8 |
   Cultural factors | 6.2 |
   Fear | 6.2 |